Adebrelimab plus chemotherapy vs. chemotherapy for treatment of extensive-stage small-cell lung cancer from the US and Chinese healthcare sector perspectives: a cost-effectiveness analysis to inform drug pricing

Gan, YN; Shi, FH; Zhu, H; Han, S; Li, DD

Li, DD (通讯作者)，Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing, Peoples R China.

FRONTIERS IN PHARMACOLOGY, 2023; 14 ():

Abstract

Purpose: The aim of this study was to evaluate the cost-effectiveness of a recently approved first-line therapy (adebrelimab plus chemotherapy vs. che......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索